This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEA6606G_M.jpg
Hologic announced earnings per share of $2.07 on revenue of $1.35B. Analysts polled by Investing.com anticipated EPS of $1.23 on revenue of $1.12B.
Hologic shares are up 41% from the beginning of the year, still down 0.85% from its 52 week high of $74.38 set on November 4. They are outperforming the S&P 500 which is up 6.58% from the start of the year.
Hologic shares gained 1.13% in after-hours trade following the report.
Hologic’s report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
